MedPath

Pediatric Pelvic Injuries - Epidemiology and Demography

Completed
Conditions
Pelvis Injury
Child, Only
Registration Number
NCT04756947
Lead Sponsor
Charles University, Czech Republic
Brief Summary

A retrospective epidemiological study of pediatric pelvic injury from level 1 trauma centre.

Hypothesis: In the pediatric population, majority of pelvic injuries is of type A according to AO/OTA (Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association) classification, the treatment is mostly conservative and complications of injury and treatment are less common than in adults.

Detailed Description

Study design: Retrospective analysis (13 years), excluding pathological fractures. AO/OTA type, epidemiological data, mode of treatment, and complications were recorded. Data were analyzed using the Fisher exact test and the Wilcoxon test.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
358
Inclusion Criteria

Not provided

Exclusion Criteria
  • Pathological fractures

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Epidemiological study of pediatric pelvic traumaFollow-up of each patient for minimum 12 months.

1. The overall incidence of pelvic ring injury per 100,000 children per year.

2. The overall incidence of isolated acetabular fractures per 100,000 children per year.

3. The overall incidence of combined pelvic ring and acetabular injuries per 100,000 children per year.

Secondary Outcome Measures
NameTimeMethod
Demographical study of pediatric pelvic traumaFollow-up of each patient for longer then 12 months.

1. Comparison of the incidence of observed injuries by sex.

2. Comparison of the incidence of observed injuries according to the severity of trauma (single trauma vs. multiple trauma).

3. The incidence of the types of pelvic ring injury (according to AO/OTA classification) per 100,000 children per year.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.